DexCom had 13 patents in digitalization during Q1 2024. DexCom Inc’s patents filed in Q1 2024 focus on inter-app communications on mobile devices and optimized delivery of communications to users of a software application. The first patent involves a data structure for transitioning and distributing data between software applications in a shared app group, while the second patent involves delivering content to user cohorts based on selection criteria and measuring engagement outcomes. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights DexCom Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

DexCom grant share with digitalization as a theme is 7% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Methods for providing an alert or an alarm to a user of a mobile communications device (Patent ID: US20240091442A1)

The patent filed by DexCom Inc. describes methods, devices, and systems for inter-app communications on a mobile device, specifically focusing on transitioning and distributing data between software applications within a shared app group. The disclosed system includes a data structure with a scheme field providing a scheme ID to transition between software apps and a payload field for data distribution, encrypted for security.

The patent further details a mobile communications device with multiple software applications for managing glucose measurements and insulin dosages. The device can receive glucose data, calculate insulin dosages based on this data and patient-specific input, and transmit commands to an insulin delivery device for administering the dosage. The system involves storing and retrieving data in a shared database, encryption methods for data security, and communication between different software applications using an inter-application communications architecture. These innovations aim to streamline and enhance the management of glucose levels and insulin dosages for patients using mobile devices.

To know more about GlobalData’s detailed insights on DexCom, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.